Fulgent Genetics, Inc. (FLGT)
23.01
-0.17
(-0.73%)
USD |
NASDAQ |
Feb 23, 16:00
23.01
0.00 (0.00%)
After-Hours: 18:51
Fulgent Genetics Shareholders Equity (Quarterly) : 1.126B for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Delcath Systems, Inc. | 114.85M |
| Quest Diagnostics, Inc. | 7.17B |
| CytoSorbents Corp. | 9.02M |
| Cardiac Biotech Solutions, Inc. | -2.230M |
| Odyssey Health, Inc. | -7.155M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.215B |
| Total Liabilities (Quarterly) | 93.81M |
| Debt to Equity Ratio | 0.0071 |
| Current Ratio | 7.005 |
| Net Debt Paydown Yield | 0.15% |